EX-21 6 y50144exv21.htm EX-21: SUBSIDIARIES EX-21
 

Exhibit 21
 
Schering-Plough Corporation and Subsidiaries
 
Subsidiaries of the Registrant As of
December 31, 2007
 
     
    State or Country of
    Incorporation or
Subsidiaries of Registrant
 
Organization
 
AESCA Pharma GmbH
  Austria
Avondale Chemical Co. Ltd. 
  Ireland
Beneficiadora e Industrializadora S.A. de C.V. 
  Mexico
Dashtag
  United Kingdom
Diosynth RTP Inc. 
  U.S.A.
DNAX Research, Inc. 
  California
Douglas Industries, Inc. 
  Delaware
Essex Asia Limited
  Hong Kong
Essex Chemie A.G. 
  Switzerland
Essex Holdings GmbH
  Germany
Essex Italia S.p.A. 
  Italy
Essex Pharma GmbH
  Germany
Fulford (India) Limited
  India
Global Animal Management Inc. 
  Delaware
Hydrochemie GmbH
  Germany
Intervet Deutschland GmbH
  Germany
Intervet do Brasil Veterinaria Ltda
  Brazil
Intervet Holding B.V.
  Netherlands
Intervet Inc. 
  U.S.A
Intervet Innovation GmbH
  Germany
Intervet International B.V. 
  Netherlands
Intervet International GmbH
  Germany
Intervet International Inc. 
  U.S.A.
Intervet Mexico S.A. de C.V. 
  Mexico
Intervet Nederland B.V. 
  Netherlands
Intervet Pharma R&D S.A. 
  France
Intervet Productions SA
  France
Intervet Productions Srl
  Italy
Intervet UK Ltd
  United Kingdom
Intervet UK Production Ltd
  United Kingdom
Interveterinaria SA de CV
  Mexico
Laboratorios Intervet S.A. 
  Spain
MSP Technology (US) Company LLC
  Delaware
Multilan AG
  Switzerland
N.V. Organon
  Netherlands
Nanjing Organon Pharmaceutical Co., Ltd. 
  China
Nippon Organon K.K. 
  Japan
Nobilon International B.V. 
  Netherlands
Organon (Ireland) Ltd. 
  Ireland
Organon AG
  Switzerland


138


 

     
    State or Country of
    Incorporation or
Subsidiaries of Registrant
 
Organization
 
Organon Agencies B.V. 
  Netherlands
Organon Belgie NV
  Belgium
Organon BioSciences International B.V.
  Netherlands
Organon BioSciences Nederland B.V. 
  Netherlands
Organon BioSciences N.V.
  Netherlands
Organon BioSciences Reinsurance Limited
  Ireland
Organon China B.V. 
  Netherlands
Organon Development GmbH
  Germany
Organon Europe B.V. 
  Netherlands
Organon Holding B.V. 
  Netherlands
Organon International B.V. 
  Netherlands
Organon International Inc. 
  U.S.A.
Organon Laboratories Ltd. 
  United Kingdom
Organon Mexicana S.A. de C.V. 
  Mexico
Organon Middle East Ltd. Cyprus
  Cyprus
Organon Nederland B.V. 
  Netherlands
Organon Participations B.V. 
  Netherlands
Organon Polska Sp. z.o.o. 
  Poland
Organon S.A. 
  France
Organon USA Inc. 
  U.S.A.
P.T. Schering-Plough Indonesia
  Indonesia
Sherico, Ltd. 
  Switzerland
Schering Bermuda Ltd
  Bermuda
Schering Corporation
  New Jersey
Schering-Plough (China), Ltd. 
  Bermuda
Schering-Plough (Ireland) Company
  Ireland
Schering-Plough (Proprietary) Limited
  South Africa
Schering-Plough (Singapore) Pte. Ltd. 
  Singapore
Schering-Plough (Singapore) Research Pte. Ltd. 
  Singapore
Schering-Plough A/S
  Denmark
Schering-Plough AB
  Sweden
Schering-Plough Animal Health Corporation
  Delaware
Schering-Plough Animal Health Kabushiki Kaisha
  Japan
Schering-Plough Animal Health Limited
  Thailand
Schering-Plough B.V. 
  Netherlands
Schering-Plough C.A. 
  Venezuela
Schering-Plough Canada, Inc. 
  Canada
Schering-Plough Central East A.G. 
  Switzerland
Schering-Plough Compania Limitada
  Chile
Schering-Plough Corporation
  Philippines
Schering-Plough del Caribe, Inc. 
  New Jersey
Schering-Plough del Ecuador, S.A. 
  Ecuador
Schering-Plough del Peru S.A. 
  Peru
Schering-Plough Farma Lda. 
  Portugal
Schering-Plough HealthCare Products, Inc. 
  Delaware
Schering-Plough Holdings (Ireland) Company
  Ireland


139


 

     
    State or Country of
    Incorporation or
Subsidiaries of Registrant
 
Organization
 
Schering-Plough Holdings France, SAS
  France
Schering-Plough Holdings Limited
  United Kingdom
Schering-Plough Home Again LLC
  Delaware
Schering-Plough II — Veterinaria, Lda. 
  Portugal
Schering-Plough International C.V. 
  Netherlands
Schering-Plough International Finance Company B.V. 
  Netherlands
Schering-Plough International Holdings B.V. 
  Netherlands
Schering-Plough International, Inc. 
  Delaware
Schering-Plough Investments Company GmbH
  Switzerland
Schering-Plough Israel A.G. 
  Switzerland
Schering-Plough Kabushiki Kaisha
  Japan
Schering-Plough Korea
  Korea
Schering-Plough Labo N.V. 
  Belgium
Schering-Plough Legislative Resources, L.L.C. 
  Delaware
Schering-Plough Limited
  Taiwan
Schering-Plough Limited
  Thailand
Schering-Plough Limited
  United Kingdom
Schering-Plough Ltd. 
  Switzerland
Schering-Plough N.V./S.A. 
  Belgium
Schering-Plough Pharmaceutical Industrial and Commercial S.A. 
  Greece
Schering-Plough Products Caribe, Inc. 
  Cayman Islands
Schering-Plough Products LLC
  Delaware
Schering-Plough Products, Inc. 
  Delaware
Schering-Plough Produtos Farmacuticos Ltda. 
  Brazil
Schering-Plough Pty. Limited
  Australia
Schering-Plough S.A. 
  Panama
Schering-Plough S.A. 
  France
Schering-Plough S.A. 
  Argentina
Schering-Plough S.A. 
  Colombia
Schering-Plough S.A. 
  Spain
Schering-Plough S.A. de C.V. 
  Mexico
Schering-Plough S.p.A. 
  Italy
Schering-Plough Saude Animal Industria E Comercio Ltda. 
  Brazil
Schering-Plough Sdn. Bhd. 
  Malaysia
Schering-Plough Technologies Pte. Ltd
  Singapore
Schering-Plough Tibbi Urunler Ticaret, A.S. 
  Turkey
Schering-Plough Veterinaire
  France
Sentipharm A.G. 
  Switzerland
Shanghai Schering-Plough Pharmaceutical Company, Ltd. 
  China
SOL Limited
  Bermuda
SP Flight Operations, Inc. 
  Delaware
SP Healthcare Products Corp. 
  Delaware
S-P Holding GmbH
  Austria
Summit Property Company LLC, The
  Delaware
Theriak B.V. 
  Netherlands
Vetrex B.V. 
  Netherlands


140


 

     
    State or Country of
    Incorporation or
Subsidiaries of Registrant
 
Organization
 
Warrick Pharmaceuticals Corporation
  Delaware
Werthenstein Chemie A.G. 
  Switzerland
White Laboratories, Inc. 
  New Jersey
Zao Organon A/O
  Russian Federation
 
In accordance with Item 601(b)(21) of Regulation S-K, the Registrant has omitted the names of particular subsidiaries because the unnamed subsidiaries, considered in the aggregate as a single subsidiary, would not have constituted a significant subsidiary as of December 31, 2007.


141